Pre-hospital Analgesia Wollongong CGD August 13 th Dr. Kent Robinson.

Slides:



Advertisements
Similar presentations
Moderate Sedation Review 2008
Advertisements

Opioid Pharmacology: How to choose and how to use Romayne Gallagher MD, CCFP Division of Palliative Providence Health Care.
Title – xxx Speaker Implementing paediatric procedural sedation in emergency departments: 2013 Ketamine Dr David Krieser FRACP Paediatric Emergency Physician,
Narcotic agonist/narcotic analgesic. Mechanism of Action: Alleviates pain by acting on the pain receptors in the brain; elevates pain threshold. Depresses.
Julie Latimer DANA NSW Drug & Alcohol Nurses Forum September 2014.
VECURONIUM BROMIDE Familiarization Training. General Information Vecuronium is a non-depolarizing neuromuscular blocking agent, preventing acetylcholine.
Dr. Kelly Mayson, Vancouver Coastal Health.  Select from the list the principle anesthesia technique used  The technique employed may be found on the.
Sedation & Analgesia PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2010.
1 F ‘08 P. Andrews, Instructor. 2 We’ll talk about  Buprenex  Stadol  Vicodin  Demerol  Morphine sulfate  Fentanyl  Nubain  Trexan  Narcan 3.
Fentanyl. Fentanyl Basics  First synthesized in Belgium in the 1950’s for anesthesia  Trade Name “Sublimaze”  It is a potent synthetic narcotic with.
Procedural Sedation: Deb Updegraff, R.N., M.S.N. P.N.P. Clinical Nurse Specialist Pediatric Intensive Care 3S Intermediate Intensive Care LPCH.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
Oral Sedation.
Procedural Sedation Pharmacology Deb Updegraff R.N., P.N.P, C.N.S. Clinical Nurse Specialist LPCH Pediatric Intensive Care Unit.
Revised 5/2008 Pain Management Introduction for incoming Trainees. Includes UMHHC specific information. “clicking” will progress you thru the slide show.
Sedation and Analgesia for Diagnostic and Therapeutic Procedures Michael S. Mazurek, M.D. Associate Professor of Clinical Anesthesia Riley Hospital for.
GENERAL ANAESTHESIA M. Attia SVUH Feb.2007.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 12 General Anesthetics.
Terry Roumayah RN, BSN, SRNA, CCRN Oakland University/Beaumont Hospital Graduate Program of Nurse Anesthesia.
PAIN ASSESSMENT PURPOSE  To provide guidelines for the appropriate identification and assessment of patients who may experience pain.
. Moderate Sedation Review 2009 Part 2: Pharmacology.
Intravenous anesthetic agents. Intravenous Anesthetics BarbituratesBenzodiazepinesOpioids Miscellaneous drugs.
Conscious Sedation. Sedation and Analgesia O “ A state that allows patients to tolerate unpleasant procedures while maintaining adequate cardiorespiratory.
MEDICATIONS. Medications Epinephrine Volume expanders Sodium bicarbonate Naloxone Dopamine.
Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration Troy Tada,
Obstructive Sleep Apnea of Obese Adults Obstructive Sleep Apnea of Obese Adults Pathophysiology and Perioperative Airway Management Anesthesiology, 2009,
Prepared by : Areen Zraikah Dana Fatayer. Pharmacology: Naloxone and nalmefene are pure opioid antagonists that competitively block mu, kappa, and delta.
Pain Most common reason people seek health care Tissue damage activates free nerve endings (pain receptors) Generally indicates tissue damage.
PENTHROX™ - Methoxyflurane
Sedation, Analgesia and Paralytics in the ICU
General Anesthesia Dr. Israa.
Procedural Sedation for Adult Patients. By relieving anxiety, reducing pain, and providing amnesia, sedation techniques have the potential to render potentially.
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
By: Dr. safa bakr M.B.Ch.B. ,H.D.A. ,F.I.B.M S.
2009 Pandemic Education Package Pharmacology Review.
PRE-OPERATIVE PRE - MEDICATION. Pre-medication  Pre-medication is the administration of drugs before anesthesia.  Pre-medication is used to prepare.
CNS Depressants Lab # 2.
Narcotic agonist/narcotic analgesic. Mechanism of Action: Alleviates pain by acting on the pain receptors in the brain; elevates pain threshold. Depresses.
Otto F Sabando DO FACOEP Program Director Emergency Medicine Residency St. Joseph’s Regional Medical Center Paterson NJ.
Cervical Block. Spinal anesthesia Spinal anesthesia : Subarachnoid or intrathecal anaesthetia- the drug is injected into subarachnoid space so it.
Welcome! Webinar participants Please be sure your mic is on mute You can send messages in the chat pane Mute Cellphones 1.
Breakthrough, emergency, and incident pain
Side effects and toxicity of analgesics Disclaimer: This presentation contains information on the general principles of pain management. This presentation.
Ondansetron Tactical Combat Casualty Care Guideline Change Dec 14.
Introduction to anaesthesia
Prehospital Analgesia Dr David Teubner 20/7/5
بسم الله الرحمن الرحیم. Methoxyflurane – Introduction It is first time introduced in USA in ,2 dichloro – 1,1 difluoro-ethyl methyl ether Fluorinated.
Analgesia and Sedation in Intervention Radiology
PICU Analgesia & Sedation Algorithm for Endotracheally Intubated Patients Routine goal directed daily assessment. Use minimal pharmacological agents to.
Chapter 13 Pain Management.
Procedural & Emergency Sedation for EMET Townsville
Opiod analgesics 9월 흉부외과 인턴 김영재.
Opioids for the management chronic non-cancer pain in Primary Care:
General Anesthesia.
General Anesthesia.
Rocuronium New drug authorized to administer by DHS. BUT is limited to use in a successfully intubated patient. Will only be used for patients being transferred.
School of Pharmacy, University of Nizwa
Sedation and Anagesia in Critical Care
Traditional parenteral antihypertensive treatment
Dr. Mohamed AlKhayarine
Emergency Analgesia in the Trauma Setting in Adults
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
CNS Depressants Lab # 2.
Comfort Ch 41.
ACUTE PAIN MANAGEMENT FOR EMS
Morphine has been described as the gold standard of opioid therapy
Pain management (part 2)
Sedation and Analgesia in Acutely Ill Children
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Presentation transcript:

Pre-hospital Analgesia Wollongong CGD August 13 th Dr. Kent Robinson

Pain Pain is a common presentation % of all presentations to the ED are for pain related issues. Oligoanalgesia is common with the vast proportion of our patients not receiving adequate analgesia. Minimal research done on the topic of pre-hospital analgesia.

Summary Analgesia should be given early to patients in acute severe pain. Intravenous analgesia should be aggressive and titrated to effect – Results in better analgesia – Results in reduced dosages of medications

Summary Opiates should be the mainstay of analgesia – Consider the use of titrated fentanyl Rapid onset of action Quicker time to effective analgesia Use ketamine as an opioid sparing agent Consider the use of targeted analgesia such as local anaesthetic nerve blockade

Pain History Site of pain – Location – Radiation Circumstances associated with pain onset Character of pain Intensity of pain – At rest – On movement – Duration of pain – Aggravating or relieving factors

Pain History Associated symptoms (nausea) Effect of pain on sleep and activities Treatment – Current and previous medications (dose, frequency, efficacy and side effects) – Other treatments (TENS) – Health professionals consulted Relevant past medical history

Pain History Factors influencing the patients symptomatic treatment – Belief concerning the cause of pain – Knowledge, expectation and preferences for pain management – Expectations of pain treatment – Reduction in pain required for patient satisfaction – Typical coping response for stress or pain (past history of psychiatric disorders)

Measurement of Pain Complex and difficult to measure Pain is an individual and subjective experience There are no objective measures for pain – Hyperalgesia – Stress response (cortisol levels) – Behavioral response (facial expressions) – Functional impairment – Physiological responses (changes in heart rate)

Numerical Rating Score

Verbal Descriptor Scale Best choice in elderly patients including patients with mild to moderate cognitive impairment. This type of scale uses descriptor terms such as none, mild, moderate, severe and excruciating

General Principles of Pain Care Many factors can add to the pain – Situation – Movement of patient – Procedures (cannulation, limb splintage, spinal care) Patients may be anxious or confused and not think to ask for pain relief. Good analgesia facilitates patient care.

General Principles of Pain Care. Appropriate analgesia should be given via an appropriate route in the shortest time frame possible. Reassessment of pain should occur to determine the effect of treatment. If pain is severe this should happen every 5-15 minutes (severe pain is defined as a pain score greater than 7). Less severe pain should be reassessed every minutes.

General Principles of Pain Care Pain relief has medical benefits – Reduction in pain related tachycardia – Improved in lung function – Reduction in PTSD Consider targeted analgesia Pain relief should be ongoing to avoid “wind-up” and increased analgesia requirements If aggressive with analgesia, total requirements will be lower.

General Principles of Pain Care Patients with severe injuries may require high doses of analgesics which may depress their level of consciousness. – Cause hypoventilation and hypercarbia – Necessitate intubation for analgesic control.

Methoxyflurane Halogenated ether Highly potent and lipid soluble Powerful analgesic Nephrotoxic and hepatotoxic - dose dependent effect (anaesthetic dosages) Reduce pain sensitivity by altering tissue excitability

Methoxyflurane Extensively used in Australia and New Zealand in the pre-hospital setting Inhaler – green whistle 3 ml dose – lasts approximately 30 minutes Maximum recommended dose is 6 ml per day due to concerns about dose related nephrotoxicity Pain relief takes effect after 6-8 breaths and continues for several minutes after discontinuation of the drug.

Morphine Naturally occurring alkaloid derived from opium Strongly lipophobic Onset time is 5 minutes Peak effect is 10 minutes Duration of action 1-4 hours

Morphine Dosage mg/kg (repeat to effect) Moderate sedative effect Potent metabolites – analgesia and respiratory depression Unlikely to cause apnea at therapeutic doses.

Morphine Gold standard for analgesia in severe pain Average dose to control acute severe pain is 0.4 mg/kg

Fentanyl Synthetic opioid Highly lipophilic Onset time < 1 minute Peak onset 2-3 minutes Duration of action minutes Dosage mcg/kg (repeat to effect), maximum dose of 100 mcg (equivalent to 10 mg Morphine)

Fentanyl Causes minimal sedation No active metabolites High risk of apnea at therapeutic dosages High risk of chest wall rigidity syndrome Highly emetogenic compared to other opioids

Chest Wall Syndrome Muscle rigidity can occur with doses as low as 25 mcg in an adult. Often confused with apnea caused by mu-1 receptor agonism. Unable to resuscitate or ventilate patient unless given naloxone or neuromuscular blocking drug

Fentanyl Very efficacious Rapid onset of action Highly potent Probably the least safe of the opioids available, but still has a very low side effect profile.

Ketamine NMDA antagonist Rapid acting GA Profound analgesia Normal airway reflexes Increased skeletal muscle tone Stimulation of cardiovascular and respiratory system

Ketamine Contraindications – Severe hypertension would result in a hazard Adverse Reactions – Emergence reactions occur in 12% of patients (lowest incidence in the young and elderly) – BP and HR are frequently elevated – Laryngospasm and bronchorrhoea – Tonic / Clonic movements mimicking seizures

Ketamine Sub-dissociative dosage of drug – 0.25 mg/kg, repeat every 30 minutes Some studies recommend lower dosages of 1-2 mg boluses (Make up the drug into 1 mg/ml) Paediatric dosage 0-4 mcg/kg/min Background infusion of mg/kg/hr if required.

Ketamine The use of sub-dissociative doses of ketamine reduces the dosages needed of opiates Opiate sparing medication

Ketamine S+ ketamine is now becoming available Traditional ketamine contains equivalent amounts of S+ and R- ketamine. S+ Ketamine has 4 times the affinity for the NMDA receptor resulting in greater analgesic efficacy.

Targeted Analgesia Femoral nerve block – Indicated for injuries to thigh and knee – Landmarks include the inguinal crease and the femoral artery – Can improve accuracy of infiltration with the use of ultrasound

Targeted Analgesia Bupivacaine (Marcaine) – 0.25% or 0.5% strengths – Onset of action is 5 minutes – Duration of action is 2-4 hours – Duration of effect for nerve block is approximately 10 hours – Maximum dose is 2 mg/kg up to 175 mg/dose (35 mL 0.5%, 70 mL 0.25%) For femoral nerve block, the volume of LA is generally 20 mL or less

Summary Analgesia should be given early to patients in acute severe pain. Intravenous analgesia should be aggressive and titrated to effect – Results in better analgesia – Results in reduced dosages of medications

Summary Opiates should be the mainstay of analgesia – Consider the use of titrated fentanyl Rapid onset of action Quicker time to effective analgesia Use ketamine as an opioid sparing agent Consider the use of targeted analgesia such as local anaesthetic nerve blockade

References Kanowitz A et al. Safety and effectiveness of fentanyl administration for prehospital pain management. Prehospital Emergency Care. 2006; 10(1);1-7 Galinski M et al. A randomized double-blind study comparing morphine with fentanyl in prehospital analgesia. Am J Emerg Med. 2005;23(2); Borland et al. Options in prehospital analgesia. Emerg Med. 2002;14(1);77-84 Prehospital analgesia in NSW, Australia. Prehospital & Disaster Med. 2011;26(6);